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Abstract
Borderline Personality Disorder (BPD) has been previously conceptualized as an extreme variant
of normal personality traits, captured by continuous indices. A previous study successfully developed and
validated a self-report BPD measure, the Minnesota Borderline Personality Disorder Scale (MBPD). I
conducted two studies aimed at providing further validation for this measure. Results from Study 1
(clinical sample of substance users) indicated that MBPD exhibited strong positive correlations with
measures of convergent validity (self-report and diagnostic measures). Additionally, the MBPD showed
similar correlations with external correlates as those of the convergent validity measures, in addition to
incremental utility in predicting these external correlates above and beyond negative affect. Third, a
Receiver Operating Characteristic (ROC) curve analysis indicated that diagnostic accuracy of the MBPD
was excellent for differentiation between BPD and non-BPD individuals. Likewise, Study 2 (non-clinical
sample of undergraduate students followed over 6 months) showed strong correlations with an index of
convergent validity (self-report measure), similar correlations with external correlates as that of the
convergent validity index, and incremental predictive utility. Finally, in this study, the MBPD exhibited high
rank-order stability, but significant mean-level and individual-level change over time. These data suggests
that these scales are measuring the same latent construct of BPD, providing further evidence for the
construct validity of the MBPD.
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Longitudinal Validation and Diagnostic Accuracy of the MBPD
Borderline Personality Disorder (BPD) is a personality disorder marked by severe social and
functional impairment as well as poor long term outcomes (Skodol, et al., 2005; Whisman & Schonbrun,
2009; Winograd, Cohen, & Chen, 2008). Characteristics of BPD include both maladaptive behvaiors and
traits such as emotion dysregulation, outbursts of anger, impulsive and risky behaviors, self-harm,
unstable interpersonal relationships, and disturbances in self-image (Linehan, 1993; Links, Heslegrave,
Mitton, van Reekum & Patrick 1995; Livesley, Schroeder, & Jackson, 1992; McGue, Osler, & Christensen,
2010; Siever & Davis, 1991; Siever, Torgersen, Gunderson, Livesley, & Kendler, 2002; Skodol et al.,
2002a; Skodol et al., 2002b). Moreover BPD is comorbid with other psychopathology including depressive
symptoms, (Fonagy & Bateman, 2006; Perry, 1985), anxiety symptoms (Andover, Pepper, Ryabchenko,
Orrico, & Gibb, 2005; Zanarini, et al., 1998), disordered eating (Pope & Hudson, 1989; Striegel-Moore,
Garvin, Dohm, & Rosenheck, 1999), and both alcohol and substance abuse (Links et al., 1995; Paris,
1997).
Traditionally BPD has been thought of as a categorical (present or absent), “lifetime” disorder.
However, recent research has brought three advances in the understanding of BPD. The first is that, far
from being a life-long sentence, BPD traits and features fluctuate on both a short-term as well as longterm level. Prior research shows that of those originally with diagnosed BPD in adulthood, only about a
third of those met diagnostic criteria over a 1 -3 year follow-up (Paris, Brown, & Nowlis, 1987; Shea, Stout
et al., 2002; Zanarini et al., 2003b). Likewise, Bornovalova, Hicks, Iacono, & McGue (2009) showed that
BPD features are elevated in mid- and late adolescence, but steeply decline in young adulthood.
The second advance is that BPD is best conceptualized as a continuous construct (Ayers,
Haslam, Bernstein, Tryon, & Handelsman, 1999; Edens, Marcus, & Ruiz, 2008; Rothschild, Cleland,
Haslam, & Zimmerman, 2003; Wilberg, Urnes, Friis, Pedersen, & Karterud, 1999). For instance, Edens et
al. (2008) utilized three taxometric procedures to determine if BPD is taxonic (latent category) or
nontaxonic (latent dimension) and found consistently that BPD showed a non-taxonic or more
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dimensional conceptualization. And, it is now widely recognized that maladaptive personality traits are
expressed in the general population, in the absence of any full-blown disorders, but may nevertheless
signal a liability for a forthcoming disorder (Shiner, 2009). From this standpoint, personality disorders are
extreme manifestations of underlying continuous dimensions (Shiner, 2009; Rothschild, Cleland, Haslam
& Zimmerman, 2003).
The third advance is that research indicates that BPD is best conceptualized as an extreme
variant of normal personality features (e.g., Five-Factor Model; FFM; Clarkin, Hull, Cantor, & Sanderson,
1993; Costa & McCrae, 1992; Saulsman & Page, 2004; Trull, Widiger, Lynam, & Costa, 2003). For
example, Morey & Zanarini (2000) found that the neuroticism factor of the five-factor model could
distinguish between BPD and non-BPD individuals, and that in fact the entire FFM model accounted for a
significant proportion of variance in BPD diagnosis for both self-report and diagnostic measures. Further,
in three samples, undergraduate students, and two outpatient clinic samples, Trull, Widiger, Lynam,
Costa (2003) showed that a derived expert-consensus, prototypic, FFM borderline profile was associated
with well-validated diagnostic measures of BPD and theoretical constructs related to BPD.
Taking into account the success of normal personality inventories in capturing abnormal
personality disorders, a previous study used the Multidimensional Personality Questionnaire (MPQ,
Tellegen, 1982, Patrick, Curtin, & Tellegen, 2002) to create a self-report, continuous measure of BPD, the
Minnesota Borderline Personality Disorder Scale (MBPD; Bornovalova, Hicks, Iacono & McGue, 2011).
The MBPD is a 19-item scale developed using items from the MPQ (MPQ; Tellegen, 1982; Patrick,
Curtin, & Tellegen et al., 2002). Notably, the purpose of the original study was not to develop a “gold
standard” of BPD measurement. Instead, the purpose was to capitalize on the richness of existing large
datasets in which the MPQ – but, due to expense or participant burden, no measure of BPD was
administered. If a valid index of BPD could be calculated from the MPQ, then the data available from
large, longitudinal datasets (e.g., Dunedin Multidisciplinary Health Development Study) could be used to
answer questions about BPD.
The pragmatics behind the original development purpose notwithstanding, the MBPD showed
excellent validity. It was significantly correlated with both diagnostic and self-report, continuous measures
of BPD. Moreover, the MBPD provided incremental prediction of BPD symptoms over negative
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emotionality, a construct that has considerable overlap with BPD, (Bornovalova et al., 2011; Ball, Tennen,
Poling, Kranzler, & Rounsaville, 1997; Trull, 1992) indicating that this measure is not just indexing
negative emotionality. Further, the MBPD predicted external correlates of BPD such as substance use
and depression (Zanarini & Frankenburg, 1997; Zanarini et al., 1998), reinforcing that this measure
exhibits the predicted associations between BPD traits and related external constructs, reflecting the
functioning of the latent construct of BPD.
Although this scale has been through a rigorous validation process, a single validation study is
insufficient for demonstrating the validity of any measure. A follow-up validation study in independent
samples is needed for several reasons. First, cross-validation in independent samples would show that
the MBPD measures the same BPD traits independent of site or sample. Second, the original validation
study lacked a test of short-term longitudinal stability. Examining the stability of a measure provides
further evidence that the scale consistently measures BPD features at varying time points. Third, previous
validation studies (Bornovalova et al., 2011; Rojas et al., 2013) have not examined the diagnostic utility of
this measure (i.e. the ability of MBPD to differentiate between BPD and non-BPD individuals). Finally,
MBPD remained a continuous measure, and to date, no study has attempted to set a diagnostic “cutoff”
that allows for identifying individuals with BPD.
The final point – the need for a diagnostic cutoff - stands in contrast to both my view and the
wealth of research that indicates that BPD is best conceptualized continuously. However, there are at
least three practical reasons to dichotomize a continuous construct. First, having a diagnostic cutoff
allows researchers to estimate prevalence rates of BPD in large existing datasets and compare them to
well-established population estimates. Second, multiple extant studies of BPD rely and report results
obtained with a categorical BPD diagnosis (Gunderson et al., 2000; Zanarini, Frankenburg, Hennen, Silk,
2003a). The ability to calculate an approximation of a BPD diagnosis allows researchers to either
compare or replicate such studies, allowing for comparison and consistency across the BPD literature.
Finally, a diagnostic cutoff can be used as a screening or a diagnostic tool in clinical practice settings
where cutoffs are needed for screening, triage or billing purposes.

4
Overview of Current Investigation
I conducted two studies that further examined the validity of MBPD. Study 1 focused on a clinical
sample of urban substance users in residential treatment. The goals of this study were as follows. First, I
examined the convergent validity of MBPD by testing its relationship with well-established BPD measures.
Second, I examined that the MBPD supported the nomological network of BPD by investigating its
relationship with external correlates that have reliably been shown to be related to the construct of BPD.
Previous work indicated that across different measures, BPD is related to the normal personality
dimensions of trait-impulsivity, negative affect, and distress tolerance (Links et al., 1995; Whiteside &
Lynam, 2001; Gratz, Tull, Baruch, Bornovalova, & Lejuez, 2008; Bornovalova, Lejuez, Daughters,
Rosenthal, & Lynch, 2005), in addition to perceived stress (Bohus et al., 2000b) a reported history of
childhood abuse (Herman, Perry, & van der Kolk, 1989; Links, Steiner, Offord, & Eppel, 1988; Ludolph et
al., 1990; Ogata et al., 1990; Zanarini, Gunderson, Marino, Schwartz, & Frankenburg, 1989), and
internalizing and externalizing psychopathology (Eaton et al., 2011; James & Taylor, 2008; Miller, Flory,
Lynam & Leukefeld, 2003). If, in fact, the MBPD measured the latent BPD construct, then the MBPD
should be related to these variables as well. Third, I examined if the MBPD carries incremental validity
above and beyond the negative affect, a core component of BPD (Gratz, Tull, Baruch, Bornovalova, &
Lejuez, 2008; Bornovalova, Matusiewicz, & Rojas, 2011; Trull et al., 2008) of BPD symptoms and these
external correlates. Fourth, I examined the MBPD in terms of diagnostic accuracy for distinguishing
between BPD versus non-BPD individuals. Finally, I aimed to establish diagnostic cutoff points that can
be used in prevalence estimates, as well as clinical settings.
Study 2 focused on undergraduates followed longitudinally over a period of six months. As in
Study 1, I examined the convergent validity, external correlates, and incremental utility of MBPD.
Moreover, I examined the longitudinal stability of MBPD via three indices: mean-level change (or average
change over time); rank-order stability (consistency over time in individuals’ order within the population;
test-retest reliability); and individual-level change (individual differences in change or stability over time;
Baltes & Nesselroade, 1973). The use of these two diverse samples allowed me to investigate the validity
of the MBPD across populations, in turn providing support for the generalizability of the measure. For
detailed hypotheses please see Appendix A.
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Study 1: Substance Users
Participants
Participants were 227 substance users at residential substance abuse facilities. Mean age of
participants was 30.04 (SD = 8.40), and the sample was roughly equally split by gender (47% male, 53%
female). Participants were 69.5% Caucasian, 13.5% African American, and 17% Hispanic. Regarding
education, 22.4% had at least some college education, 17% completed high school or had a GED, and
20% did not complete high school. All participants completed a battery of questionnaires, and a clinical
interview was verbally administered. In order to measure reliability, 25% of the audio-taped interviews
were rated independently for symptom count and diagnosis by two raters who are trained research
assistants. If there were discrepancies in symptom ratings and/or diagnosis, consensus was reached
through the aid of a PhD level clinician (M.B.). Participants were compensated with $20 for completion of
the assessment. All participants were provided written consent after written and oral assurances of
confidentiality. The study was approved by the University of South Florida Institutional Review Board. As
there was large overlap between Study 1 and Study 2 measures, and I aimed to increase the readability
of the manuscript, Table 1 presents a summary of study measures and reliabilities, whereas Appendix A:
Table A1, shows the schedule of assessments, and Appendix B shows a full, detailed description of the
measures.
Convergent Validity
To establish the convergent validity of the MBPD, I examined its relationship with established
BPD measures: the PAI-BOR and the SCID-II symptom counts of BPD. Pearson correlations were used
to test the association between MBPD and the PAI-BOR and the SCID-II BPD symptom counts.
As seen in Table 2, the MBPD exhibited strong, positive, correlations with both the PAI-BOR (r = .70) and
SCID-II BPD symptoms (r = .62).
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External Correlates
In accordance with previous studies (Bornovalova et al., 2011; Verona, Hicks, & Patrick, 2005;
Zanarini, 2000; Zanarini & Frankenburg, 1997; Zanarini et al., 1998) and the nomological network of BPD,
I examined the relationship between MBPD and its external correlates. First, I examined Pearson
correlations between the MPBD and normal personality dimensions (negative and positive affect, trait
impulsivity, externalizing traits, distress tolerance), measures of perceived and actual stressors (perceived
stress, childhood abuse), Axis II psychopathology (conduct disorder symptoms, adult antisocial
behaviors), Axis I psychopathology (depression, anxiety, alcohol and substance use dependence
symptoms) and self-report alcohol use and drug use. As expected, MBPD exhibited significant
correlations (ps<.01) with negative affect, trait impulsivity, externalizing traits, distress tolerance,
perceived stress, and childhood trauma (Table 2). In support of its discriminant validity and consistent
with previous research (Rojas, et al., in press; Miller, Gentile, Wilson, Pryor, & Campbell, 2010), the
MBPD did not show significant correlations with positive affect or sensation seeking. In terms of
psychopathology, the MBPD exhibited the expected significant correlations with both Axis I and II
psychopathology and self-reported drug and alcohol use (rs ranged from .18 - .45 p <.01), but failed to
correlate with substance dependence and alcohol dependence.
Next, if the MPBD is indeed measuring the latent BPD construct, it should be correlated with the
same external correlates as the PAI-BOR and SCID-II symptom count. And, the magnitude of its
relationship with external correlates should be similar to the magnitude of the PAI-BOR and SCID-II
symptoms with the external correlates. In order to investigate the latter, I performed Fisher R-Z
transformations to test if the difference in the magnitude of the correlations were significant (p<.01).
Results (Table 2) indicated that in almost all cases, the MBPD was related to the same external correlates
as the PAI-BOR and the SCID-II symptoms. And, as seen in Table 2, in all cases, the magnitude of the
relationship of MBPD with external correlates did not differ from the magnitude of the association of PAIBOR and SCID-II with the same external correlates. However, it is important to note that the MBPD did
exhibit a significant correlation with past-year substance whereas the PAI-BOR did not. Additionally, the
MBPD exhibited a significant correlation with positive urgency while the SCID-II did not. Conversely, the
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SCID-II exhibited additional significant correlations with alcohol and substance dependence, but the
MPBD failed to do so.
Incremental Utility
In order to test that the MBPD predicts these external correlate above and beyond negative affect
– a construct that frequently overlaps with BPD, I performed a series of linear regressions that included
the predictors of age, sex, and negative affect in Step 1, and MBPD as an additional predictor in Step 2
predicting each external correlate individually. First and foremost, the MBPD significantly predicted BPD
symptoms (B = .52, ΔR2 = .22, p <.01) indicating that the MBPD accounted for significant variance in BPD
symptoms above and beyond negative affect alone. As seen in Table 3, MBPD showed incremental utility
for normal personality variables of two indices of trait-impulsivity and distress tolerance. Next, it showed
incremental prediction of perceived stress and history of childhood abuse. Finally, for psychopathology,
the MBPD significantly predicted all Axis II and I psychopathology symptoms but not substance use or
alcohol use frequency.
Diagnostic Accuracy and Diagnostic Cutoff Points
Finally, I examined the sensitivity and specificity of MBPD in discriminating between BPD and non
BPD individuals, and in doing so, I established diagnostic cut-off points as well. To do so, I performed a
Receive Operator Curve (ROC) curve analysis to investigate the area captured under the curve by the
MBPD. The ROC analysis plots the number of individuals classified as meeting BPD diagnosis on the
SCID-II (true positive rate or sensitivity) on the ROC curve, by the number of individuals falsely classified
as meeting BPD diagnosis (false positive rate or 1 – specificity). Out of 227 substance users, 115 were
classified as meeting BPD diagnosis and 111 were classified as not meeting BPD diagnosis, with 1
missing case. A value of 0.50 indicates no discrimination or change, while a value of 1.0 indicates perfect
discrimination between BPD individuals and on BPD individuals (Swets, 1996; Mcfall & Treat, 1999).
Although there are no extant “hard” rules for establishing diagnostic cutoff points, the current practice is to
set them at points which provide the maximum balance between sensitivity and specificity (van Erkel &
Pattynama, 1998).
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Results of the ROC analysis on the MBPD indicated an excellent level of discrimination for
accurately distinguishing between BPD individuals and non BPD individuals, such that the area under the
curve was .80 (95% CI: 0.74 – 0.86). As for the diagnostic cutoffs, there were two acceptable cutoff points
(visual representation provided in Figure 1). At the cut-off score 10.77, the sensitivity was 70% and the
specificity was 80%, resulting in type I error of 20%. This cut-off classified 70% people as true positive,
19% as false positive, 30.4% as false negative, and 80.7% as true negative. At a more liberal estimate, a
cutoff score of 10.09, the sensitivity was 78% and the specificity was 72%. This results in a type I error
rate of 28%. Additionally, this cut-off classified 78% as true positive, 28.4% as false positive, 22.3% as
false negative, and 71.6% as true negative. Previous studies suggest including both a conservative cut
score (definite diagnosis or having the required number of symptoms to meet the diagnostic cut-off) along
with a more liberal diagnostic cut score (probable diagnosis or meeting one less symptom than the
diagnostic cut-off). This method included individuals who may have difficulty with reporting symptoms
(e.g. underreporting symptoms) due to reliance on memory (Kessler et al., 2003), and those who have
subclinical diagnoses (not meeting the threshold of DSM-IV criteria) but still exhibit significant impairment
(Pickles et al., 2001; Kessler et al., 2003). As a conservative cut-score (definite diagnosis) often provides
an extreme estimate, resulting in underestimation of those meeting clinical diagnosis (Elkins, King,
McGue, & Iacono, 2006; King, et al., 2009), I included a more liberal cutscore in order to generate a more
inclusive estimate. Thus, I created two diagnostic cutoffs: a probable cutoff (a score of 10) and a more
conservative, cutoff (a score of 11). Notably, as scores on the MBPD are integers, integer cutoff values
were used.
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Table 1.
Assessment Measures
Variable

Instrument

Description

Received In:

Reliability

Target
Measure

MBPD (Bornovalova, Hicks,
Patrick, Iacono, & McGue,
2011)

Putative indicator of BPD
traits

Study 1 and
Study 2

s = .76 - .77

Self-report

Personality Assessment
Inventory (PAI-BOR; Morey,
1991)

Self-report continuous
measure of BPD traits

Study 1 and
Study 2

s = .86 -.72

Diagnostic

SCID-II for BPD (Structured
Clinical Interview for DSMIV Axis II Disorders; First,
Gibbon, Spitzer, Williams &
Benjamin, 1997)

BPD symptom count from
diagnostic interview

Study 1

 = .74

Convergent

External Correlates - Personality and
Trauma History
Negative and
Positive
Affect

Positive and Negative Affect Self-report measure of
(PANAS; Watson & Clark,
state negative and
1988)
positive affect

s = .72 - .85

Trait
Impulsivity

UPPS-P Impulsive Behavior
Scale (UPPS-P; Lynam,
Smith, Whiteside, & Cyders,
2006)

Negative urgency, (lack
of) premeditation,
perseverance, sensationseeking, positive urgency,
scales of UPPS

s = .82 - .90

EXT
inventory

Externalizing Behaviors
(EXT-159; Venables,
Patrick, 2012).

Externalizing traits and
behaviors

Distress
Tolerance

Frustration Discomfort
Scale (FDS Harrington,
2005)

Self-report measures of
individual’s tolerance of
psychological distress

Distress Tolerance Scale
(Simons & Gaher, 2005)
Tolerance of Negative
Affective States (TNASS Bernstein and Brantz, 2012)

Study 1 and
Study 2

s = .74 - .92

Study 1

 = .99
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Table 1 continued
Perceived
Stress

Childhood
Abuse

Perceived Stress Scale
(PSS – Cohen &
Williamson, 1988)

Self-report of stress in
daily life over the last
month

Childhood Trauma
Questionnaire (CTQ;
Bernstein et al., 2003)

Childhood sexual,
physical, emotional abuse

s .86–.96

Study 1 and
Study 2

Factor loadings
>|.5||

External Correlates – Psychopathology
CD

AAB

SCID-II for Antisocial
Personality Disorder
(Structured Clinical
Interview for DSM-IV Axis II
Disorders; First, Gibbon,
Spitzer, Williams &
Benjamin, 1997)

 =.96

Symptom counts for
conduct disorder
Symptom count of adult
antisocial behaviors

Study 1

 = .67

Depression

Symptom counts of
lifetime and current major
depressive disorder

s = .79 – 1.00

Anxiety

Composite of symptom
counts for lifetime panic
disorder, current posttraumatic stress disorder,
current generalized
anxiety disorder

s .74-1.00

Alcohol
Dependence

Mini International
Neuropsychiatric Interview
(M.I.N.I.; Sheehan, Janavs,
Baker, & Harnett-Sheehan,
1999)

Substance
Dependence

Alcohol Use

Substance
Use

Symptom count for
current alcohol
dependence

Study 1 and
Study 2

s = .96 -1.00

Maximum endorsed
symptoms across
amphetamines, cannabis,
cocaine, hallucinogens,
inhalants, opioids, PCP,
and sedatives
National College Health
Risk Behavior Survey
(NCHRBS; Center for
Disease Control, 1997)

Past year alcohol use

Past year substance
abuse

s = 1.00 -1.00

Study 1 and
Study 2

—2

—2
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Table 1 continued
Note: Diagnostic reliability was calculated using the kappa coefficient (), scale internal consistency was
evaluated using Cronbach’s alpha (),composite measure was calculated utilizing a principals component
analysis (PCA), the reliability of a composite measure composed of multiple measures was computed
separately for each measure (Cronbach’s alpha). The alpha could not be computed because of the small
number of items (three or less). Study 1 refers to substance users; Study 2 refers to college students.
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Table 2.
Substance Users Correlations between Convergent Validity Measures and External
Correlates

MBPD

PAI-BOR

BPD
Symptoms

MBPD-PAI
Contrast Z

MBPD-BPD
Contrast Z

MBPD

-----------

.70**

------------

------------

-----------

PAI-BOR

-----------

-----------

.61**

1.51

------------

BPD Sx
.62**

-----------

------------

--------------

------------

PANAS-PA

-.03

-.01

-.07

-.29

.40

PANAS-NA

.40**

.49**

.37**

-1.16

.37

Positive
Urgency

.27**

.34**

.16

-.82

1.07

Negative
Urgency

.34**

.50**

.30**

-1.89

.49

Lack of
Perseverance

.24*

.39**

.29**

-1.61

-.47

Lack of
Premeditation

.20*

.41**

.24*

-2.26

-.37

Sensation
Seeking

.00

.08

.02

-.77

-.14

EXT

.45**

.50**

.39**

.-.67

.76

Distress
Tolerance

-.42**

-.51**

-.46**

1.13

.43

Childhood
Abuse

.31**

.33**

.36**

-.22

-.54

Perceived
Stress

.41**

.56**

.39**

-2.02

.25

Conduct
Disorder Sx

.32**

.18**

.23**

1.50

1.01

Adult Antisocial
Behavior Sx

.45**

.46**

.50**

-.12

-.68

.56**

.52**

.60**

.65

-.63

Anxiety Sx
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Table 2 continued

Major
Depressive Sx

.39**

.40**

.56**

-.05

-2.25

Alcohol
Dependence
Sx

.16

.17

.20*

-.05

-.44

Substance
Dependence
Sx

.13

.11

.30**

.22

-1.89

Past-year
Alcohol Use

.21**

.24**

.17**

-.31

.40

Past-year
Substance Use
.25**
.18
.20*
.76
.54
Note. *p<.01, **p<.001. MBPD-PAI/MBPD-BPD contrast Z indicate difference in magnitude between
correlations between MBPD and external correlates compared to convergent validity measures and
external correlates. Negative contrast z indicates that the correlations for the convergent validity
measures (PAI-BOR/SCID-II BPD symptoms) are higher. Sx = symptoms
.
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Table 3.
Predictive Utility of MBPD of External Correlates in Substance Users.
Step 1

Step 2

Age

Sex

NA

Multiple
R

R2 Δ

Age

Sex

NA

MBPD

Multiple
R

R2 Δ

BPD Sx

.-.08**

-.26**

.32**

.45

.20**

.01

-.21**

.13

.52**

.65

.22**

Positive
Urgency

-.10

.08

.12

.17

.03

-.05

.11

.02

.27*

.30

.06*

Negative
Urgency

-.08

-.03

.19

.21

.04

-.03

-.01

.07

.30**

.34

.07**

Lack of
Premeditation

-.11

-.25*

.19*

.35

.12**

-.09

-.24*

.16

.10

.36

.01

Lack of
Perseverance

.00

-.11

.33**

.36

.13**

.02

-.10

.28**

.13

.38

.01

Sensation
Seeking

-.17

.09

-.06

.22

.05*

.16

.10

-.07

.03

.22

.00

EXT inventory

-.15

06

.27**

.31

.10**

-.09

.11

.13

.40**

.47

.13**

Distress
Tolerance

.08

.05

-.34**

.35

.12**

.03

.02

-.22*

-.33**

.47

.09**

Perceived
Stress

-.18*

-.11

.44**

.50

.25**

-.14

-.09

.35**

.23*

.54

.04*

Childhood
Abuse

.14

-.25**

.03

.31

.10**

.19*

-.23*

-.08

.29**

.41

.07**

Conduct
Disorder Sx

-.20*

.18

.05

.29

.08*

-.14

.21*

-.08

.36**

.43

.11**

.
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Table 3 continued
Adult Antisocial
Behaviors

-.01

-.07

.19

.24

.06*

-.01

-.07

.04

.40**

.43

.13**

Major
Depressive
Disorder Sx

.05

-.24*

.29**

.42

.17**

.10

-.21*

.17

.30**

.50

.07**

Anxiety

.07

-.12

.45**

.49

.24**

.15

-.07

.27**

.46**

.64

.17**

Alcohol
Dependence Sx

.04

-.03

.07

.09

.01

.07

-.01

-.01

.20

.20

.03

Substance
Dependence Sx

.02

-.15

.15

.24

.06

.02

-.15

.14

.04

.24

.00

Past-Year
Alcohol Use

.05

.05

.12

.13

.02

.08

.07

.04

.21

.22

.03

Past-Year
Substance Use

-.18

-.05

.12

.22

.05

-.14

-.03

.04

.20

.28

.03

Note. * p<.01, **p<.001.Standardized regression weights are presented. Age, sex, and negative affect entered at Step 1, MBPD added at Step 2.
Sx = symptoms
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Figure 1. Substance Users ROC Curve
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Study 2: Undergraduate Students
Participants
Participants were 348 University of South Florida undergraduates recruited from the SONA
subject pool of Psychology students. Approximately half of these students (N = 233) were followed
longitudinally across three time points, termed Assessment 1 (A1), A2 (M = 91.64 days later, SD = 64.85)
and A3 (M =91.67 days after A2, SD = 61.22). Mean age was 20.47 (SD = 4.30) with 25% males, 75%
females. The ethnicity breakdown was, 52% Caucasian, 16% African-American, 20% Hispanic/Latino,
11% Asian/Southeast Asian, and 1% Native American. The follow up rate was 88% at A2 and 79% at A3.
All participants completed a battery of questionnaires, and a clinical interview was verbally administered.
All procedures were identical at each assessment time point, and the clinical interview reliability
procedure was identical to that used with the substance user sample. Participants received $20 for
completion of each study visit. All participants were provided written consent after written and oral
assurances of confidentiality. The study was approved by the University of South Florida Institutional
Review Board. Table 1 presents a summary of study measures and reliabilities.
Convergent Validity and External Correlates
Similar to the results among substance users, MBPD exhibited strong, positive, correlations with
the convergent validity measure, the PAI-BOR (Table 4).
Next, as seen in Table 4, the MBPD exhibited significant correlations with the normal personality
dimensions of most indices of impulsivity, negative affect, and distress tolerance as well as with perceived
stress but not history of childhood abuse. In contrast to the results with substance users, the MBPD was
not significantly related to lack of premeditation or childhood abuse. In support of its discriminant validity,
the MBPD did not correlate with sensation seeking or positive affect – a result consistent with the results
among substance users and previous work (Rojas et al., 2013; Miller et al., 2010). With regards to
psychopathology, the MBPD exhibited significant correlations with anxiety symptoms, MDD, and self-
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report past year substance use (rs = .15 – 53, p<.01), with the exception of the relationship with past-year
substance use, which was again similar to that of Study 1.
As in Study 1, I examined a) if MBPD is correlated with the same external correlates as the PAIBOR, and b) if the magnitude of its relationship with external correlates is similar to the magnitude of the
PAI-BOR external correlates. Results (Table 4) indicated that that in almost every case, the MBPD was
related to the same external correlates as the PAI-BOR. And, comparisons of the magnitude of
associations indicated no significant differences. It is important to note, that the PAI-BOR did exhibit an
additional significant relationship with childhood abuse, while MBPD failed to exhibit this relationship. This
indicated that the MBPD and PAI-BOR show virtually the same magnitude of relationship with external
correlates.
Incremental Utility
Next, I examined if the MBPD predicts external correlates above and beyond negative
emotionality. As in Study 1, for each external correlate, I fit two regression models, in Step 1, I entered
age, sex, and negative affect, and in Step 2, I entered MBPD. Results (Table 5) indicated that, even after
accounting for negative affect, MBPD significantly predicted indices of impulsivity, distress tolerance,
perceived stress, and a history of childhood abuse. Next, MBPD predicted anxiety symptoms, and MDD
symptoms, but neither alcohol nor substance use disorders or frequency of use. Overall, these results
indicated that the MBPD is in fact predicting correlates of BPD above and beyond a construct that highly
overlaps with BPD, supporting its incremental utility.
Rank-Order Stability
Next, I assessed rank-order stability, or the extent to which participants’ MBPD scores remained
stable, relative to that of their peers, by conducting a series of Pearson correlations between A1, A2, and
A3. MBPD exhibited high rank-order stability across the three assessment points for the entire sample
(A1 – A2: r = .67, p<.001; A2 – A3: r = .72 p<.001; A1 – A3: r = .72, p<.001). These results support that
MBPD was relatively stable over time and indicated that individuals who are relatively high at A1 are also
in the top ranges for A2 and A3.
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Mean Level Change
Before proceeding to the longitudinal analyses, I noted that participants had considerable
variability for number of days between assessments. The average number of days between A1 and A2
was 91.64 days (SD = 64.85, Range = 343 days), and between A2 and A3 was 91.67 days (SD = 61.22;
Range = 377). Thus, I regressed the variability in time between A1 and A2 (the mean number of days
between assessment and the squared term of mean number of days between assessments) from MBPD
scores at A2, and the variability in time between A2 and A3 from MBPD scores at A3.
Mean-level change refers to the magnitude of change in the average scores over time for a given
population. A repeated measures ANOVA with time as the within-level factor, and sex as the betweenlevel factor was used to determine if there was mean-level change in MBPD over three assessment time
points, and if change in MBPD scores differed by sex. In addition, univariate ANOVAs were run to identify
any gender differences in mean-level MBPD scores at each assessment. Results (Figure 2) indicated that
across assessments, there was a moderate and significant effect of time [F(2) = 14.80, p <.001, d = .58].
However, upon further investigation, these effects were found to be significant specifically between A1
and A2 [F(1) = 16.34, p <.001, d = .57], and A1 and A3 [F(1) = 20.10, p <.001, d = .67], such that there
were large effects of time. When examining the magnitude of change between A2 and A3, there was no
effect of time [F(1) = .40, p = .529, d = .09]. These results suggested that significant mean-level change
occurred between A1 and A2. Further, there was no effect of sex overall [F(1) = .01, p = .930, d = .00] or
at any specific time point (All Fs < .01; all ps = ns, all ds < .07). There was no gender by time interaction
[F(1) = 1.21, p = .272, d = .17].
Individual Level Change
Finally, I investigated individual level change in MBPD scores over time using an individual
growth curve modeling approach. This allowed me to account for the nestedness of the data such that
assessments were nested within individuals. I fit several individual growth curve models using PROC
MIXED in SAS with the Maximum Likelihood (ML) estimator that included both fixed and random effects.
The fixed effects provide mean parameter values for the sample, and the random effects refer to the
variability of the parameters estimates from the individual participants. Significant random effects indicate
that there are interindividual (between individuals) differences in intradindividual (within individuals)
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change over time. The first model, termed the ‘Unconditional Growth Model’, included a random effect of
the intercept. This model allows us to estimate the intraclass correlation (ICC) accounting for between
individual and within individual variance (Raudenbush & Bryk, 2002). The second model termed ‘Linear
Growth Model’ included time as a fixed and random effect. I compared model fit utilizing the 2 x Log
Likelihood (-2LL) ratio test to choose the more parsimonious model. The third model termed ‘Quadratic
Growth Model’ included fixed effects of the squared term of time and sex as additional predictors of
change over time. The quadratic term was included as a fixed effect only, because due to the small
degrees of freedom, estimating the variance of all parameters (intercept, slope, quadratic) may result in
finding significant results simply due to chance, thus increasing the Type I error.
Please refer to Table 6 for model fit estimates. The unconditional growth model showed that the
ICC = .65, indicating that 65% of the total variance in MBPD scores were accounted for by between
individual variance, however the remaining 35% was within individual variance. Therefore, it was
appropriate to use a multilevel modeling approach to estimate this within individual variance. First, I
compared change in model fit from the baseline model to the linear growth model using the -2LL
likelihood ratio test, Δχ2 (3) = 23.90, p <.001 and chose the latter as it showed significantly better fit.
Results for the linear growth model showed that on average (β 00) individuals scores were 7.41 at A1 or
baseline. In addition, there was considerable variance around the intercept, τ 00 = 10.91, meaning that at
baseline some individuals had higher scores while others had lower scores such that roughly 95% of
score fell between .80 – 14.01. Further, on average, individuals’ scores decreased by .0049 per day (β 10),
thus over 90 days scores decreased by .44 at A2, and over 180 days, scores decreased by .88 at A3.
These results indicated a small effect of time on the negative slope or growth rate of individuals [t(384) = 4.03, d = -.41, p<.001]. Moreover, there was a modest amount of variance in this growth rate (slope) τ 11=
.000069, suggesting that some individuals MBPD scores change at a faster rate than others, where 95%
of the range in growth rates fell between .02 -.02. Finally, negative covariance of the intercept and slope
suggested that those with higher scores change at a slower rate, z = -2.27, p <.05. The final model, the
quadratic growth model, with sex as an additional predictor showed significantly better fit than the linear
growth model using the -2LL likelihood ratio test, Δχ2 (1) = 9.20, p <.01, supporting that the addition of
the quadratic term improved model fit. Therefore, the effect of the quadratic term served to bend the
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curve of the linear trend, indicating that the rate of decline in MBPD scores starts to decrease over time,
β20 = .00003, supporting quadratic or nonlinear change over time. However, the addition of sex as a
predictor was not significant. Thus these results indicated that there was a significant effect of time on
change in individual’s scores, and that there was significant variability in this change at the individual
level. Additionally, on average, there was a small yet significant decrease in the rate of decline of change
in MBPD scores over time. Taken together these results suggested there were relatively small
interindividual differences in intraindividual change in scores over time.
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Table 4.
Undergraduate Students Correlations between Convergent Validity Measures and External Correlates

MBPD

PAI

MBPD-PAI Contrast Z

MBPD

------------

.73**

------------

PAI-BOR

------------

-------------

------------

PANAS-PA

-.12

-.20**

.85

PANAS-NA

.29**

.34**

-.51

Positive Urgency

.35**

.35**

.03

Negative Urgency

.53**

.63**

-1.43

Lack of Perseverance

.24**

.39**

-1.64

Lack of Premeditation

.11

.16

-.54

Sensation Seeking

.10

-.06

1.57

Distress Tolerance

-.41**

-.47**

.39

Perceived Stress

.52**

.61**

-1.40

Childhood Abuse

.17

.29**

-1.29

Anxiety Sx

.33**

.43**

-1.55

Major Depressive Sx

.40**

.46**

-1.09

Alcohol Dependence Sx

.07

.10

-.41

Substance Dependence Sx

.09

.11

-.32

Past-year Alcohol Use

-.01

.04

-.61

Past-year Substance Use
.15*
.17*
-.34
Note*p<.01, **p<.001. MBPD = Minnesota Borderline Personality Disorder Scale and PAI-BOR =
Personality Assessment Inventory – Borderline Scale. MBPD-PAI indicate differences in magnitude
between correlations between MBPD and external correlates compared to PAI-BOR with external
correlates. Negative signs for “Measure Difference Contrast Z” indicate that the correlation between PAIBOR and external correlates is higher. Sx = Symptoms
.
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Table 5.
Predictive Utility of the MBPD in Undergraduate Students
Step 1

Step 2

Age

Sex

NA

Multiple
R

R2 Δ

Age

Sex

NA

MBPD

Multiple
R

R2 Δ

Positive
Urgency

-.07

.25*
*

.27**

.35

.12**

-.02

.25**

.18*

.30**

.45

.08**

Negative
Urgency

-.05

.05

.26**

.26

.07*

.02

.04

.11

.51**

.55**

.23*

Lack of
Premeditation

-.05

.06

.07

.10

.01

-.04

.06

.05

.09

.13

.01

Lack of
Perseverance

-.02

.07

.26**

.26

.07*

.01

.06

.21*

.18

.31

.03

Sensation
Seeking

-.08

.28*
*

.02

.29

.08*

-.07

.27**

-.01

.10

.30

.01

Distress
Tolerance

-.01

.16

-.31**

.37

.14**

-.06

.16*

.21*

-.35**

.49

.11**

Perceived
Stress

-.08

-.13

.42**

.46

.21**

-.02

-.14

.31*
*

.39**

.59

.13**

.20*

.03

.04

.20

.04

.23*

.02

-.03

.22*

.28

.04*

.19*

-.02

.22*

.29

.08*

.23**

-.03

.13

.34**

.43

.10**

Anxiety
Symptoms

.20*

-.13

.32**

.41

.17**

.24**

-.14

.24*
*

.28**

.49

.07**

Alcohol
Dependence

.03

.23*

.06

.23

.05

.04

.23*

.04

.08

.24

.01

Drug
Dependence

-.04

.07

.01

.08

.01

-.03

.07

-.01

.09

.12

.01

Past-year
Alcohol Use

.21*

.18

.03

.27

.07*

.22*

.18

-.01

.10

.28

.01

Past-year
Drug Use

-.06

.21*

.01

.22

.05

-.04

.20*

-.03

.16

.26

.02

Childhood
Abuse
Major
Depressive
Disorder

Note. * p<.01, **p<.001.Standardized regression weights are presented. Age, sex, and negative affect entered
at Step 1, MBPD added at Step 2. Sx = symptoms
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Figure 2. Mean Level Change. Effect sizes (Cohen’s d) above each assessment time point test for gender
differences and significance levels for these differences at each assessment. There were no gender
differences at any time point.
.
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Table 6.
Individual Growth Curve Model Estimates
Unconditional Growth

Linear Growth

Quadratic Growth by
Sex

7.05 (.22)***
t(231) = 31.90***

7.41 (.25)***
t(231) = 30.00***

7.53 (.28)
t(230) = 26.43***

-.0049 (.0012)
t(384) = -4.03***

-.012 (.002)
t(383) = -4.52***

Fixed Effects
Intercept
β00 (SE)
Slope
β10 (SE)
Sex
Β30 (SE)

.13 (.49)
t(230) = .27

Acceleration Rate
β20 (SE)

.00003 (.00001)
t(383) = 3.05**

Random Effects
Variance of intercept
τ00 (SE)

9.29 (1.07)***

10.91(1.36)***

10.90 (1.35)***

Variance of slope
τ11 (SE)

.000069 (.000031)*

.000061(.000030)*

Covariance of intercept
and slope
τ10 (SE)

-.01 (.01)*

-.01 (.01)*

Residual Variance
σ (SE)

4.97 (.36)***

4.14 (.37)***

4.08 (.36)***

-2LL

3148.10

3124.20

3115.00

df
3
6
8
*p<.05, **p<.01, ***p<.001. The unconditional growth model included a random intercept only. The linear
growth model included a random intercept and slope of time. The quadratic growth model included a fixed
effect of time squared and an additional predictor of sex. Some parameter estimates are carried out
further than two decimal places to indicate actual value. -2LL = -2 Log Likelihood. df= degrees of
freedom.
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Discussion
I conducted two studies that aimed to further validate the MBPD. Overall the general expectations
regarding the construct validity of the MBPD were supported. Across both samples, the MBPD showed
strong, significant correlations with gold standard measures of BPD (self-report measure PAI-BOR and
diagnostic measure SCID-II BPD). Next, across both samples, the MBPD showed correlations with
normal personality dimensions, perceived stress, trauma, and Axis II and I psychopathology that have
been shown to be related to the BPD construct in previous studies and are part of the construct’s
nomological network (Goldman, Dangelo, & Demaso, 1993; Trull et al., 2001; Zanarini, Frankenburg,
Hennen, & Silk, 2003). These results support that in fact the MBPD is behaving as the latent construct of
BPD is expected to act. Third, in both studies, the MBPD was related to the same external correlates as
the PAI-BOR and the diagnostic BPD symptom count. Further, the magnitude of the relationships
between the MBPD and external correlates were similar to the relationships between the gold standard
measures and external correlates, showing that the MBPD is behaving much like the gold standard
measures. However, there were a few external correlates that the MBPD did not exhibit significant
correlations with but the other convergent validity measures did, and this could be due to measurement
variance or results found by chance. For example, alcohol dependence was related to SCID-II BPD
symptoms but not the PAI-BOR or MBPD, suggesting that it could be the nature of the measure rather
than actual differences in relationships between these measures and external correlates. Both these
measures were diagnostic, clinician administered interviews (SCID-II BPD, SCID-I for Alcohol
Dependence) while the PAI-BOR was a self-report continuous measure. Further due to the multiple
amount of tests performed, some differences may be due to Type I error or chance. Fourth, the MBPD
significantly predicted several external correlates above and beyond negative affect, indicating once
again that MBPD is not just measuring affective distress. Moreover, these results were similar across
samples. Taken together, these results provide further support for the validity of the MBPD in both clinical
and non-clinical samples.
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Beyond the usual construct validity indices, I have made three additional contributions regarding
the validity of this measure. First, I provided novel evidence that the MBPD displays excellent
discrimination in terms of identifying between BPD and non BPD individuals, as illustrated by the ROC
analyses. A previous study reported that that the PAI-BOR exhibits a reasonable or good level of
discrimination for accurately distinguishing between BPD individuals versus non-BPD individuals (Distel,
Hottenga, Trull, & Bornovalova, 2008), and the data indicate that the MBPD is performing as well as the
PAI-BOR. Next, I established “probable” and “definite” cutoff scores on the MBPD for the use in research
and clinical settings. As I noted in the introduction, cutoff scores allow for comparison of prevalence rates
to large epidemiological or clinical studies; comparison of results obtained with the MBPD to studies that
use the traditional diagnostic cutoff; and allows for screening, triage or billing purposes in clinical settings.
This study utilized one statistical approach to produce cut-scores; however it is important that
future studies validate these cut scores using other methodical approaches in multiple samples. For
example, one approach would be exploring Item Response Theory (IRT) based methods for choosing cut
scores (see Emons, Sjitsma, & Meijer, 2007; Hendrawan, Glas, & Meijer 2005) including those that take
into account the multidimensionality of a measure (see Reckase, 1997). Thus this could provide further
evidence that in fact the cut scores presented here show the same discriminatory ability in other samples.
Finally, I examined the short-term longitudinal stability and change of the MBPD. MBPD exhibited
high test-retest reliability or rank-order stability, indicating that individuals who scored the highest relative
to their peers on the MBPD at baseline, will remain near the top six months later. Another study that
looked at test-retest reliability of the PAI-BOR over the same time period, indicated similar rank order
stability (Trull et al., 1995). However, on a mean-level, the MBPD exhibited significant change over time,
showing moderate effects of time specifically between A1 and A2. Finally, there was small but significant
individual-level change meaning that individuals are changing at different rates, and thus average change
over time does not represent the entire sample. Moreover, this individual rate of change is not linear such
that rate of decline in scores slows over time. This individual level variability supported the construct
validity of this measure across time as evidenced by prior researchers. Previous research suggests that
BPD traits fluctuate over time (Schmideberg, 1959, Hopwood et al., 2009; Morey & Hopwood, 2012), and
that these individuals demonstrate similar intraindividual change as shown in the current study (Hopwood,
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Thomas, Markon, Wright, & Krueger, 2012). Overall, it appears that, across studies, the MBPD is
accurately measuring the latent construct of BPD.
There are several strengths to this study. First, I investigated the construct validity of the MBPD in
two fairly large samples, including clinical and non –clinical samples. Second, the samples were fairly
diverse and representative of the general ethnic break-down of the population. Third, one of the samples
was followed longitudinally, allowing for examination of test-retest reliability (also rank-order stability).
However, several limitations for this study should be noted. First, there was a gender imbalance among
the undergraduate students, such that there were nearly four times as many females in comparison to
males. It is possible that this imbalance may have skewed the results more in the direction of the females.
Although gender differences were not the main focus of this paper, it is important that future research
replicate the current work while balancing the gender breakdown, specifically in a non-clinical sample.
Secondly, the undergraduate sample lacked an additional diagnostic measure of convergent validity
which would have added to the construct validity and diagnostic ability of the MBPD in a non-clinical
sample.
In general, further validation of a short, self-report measure of BPD traits has several advantages.
For example, archival data sets, or other longitudinal, epidemiological samples that include other
psychopathology and personality measures like the Multidimensional Personality Questionnaire, but no
direct assessment of BPD traits would benefit from this measure, as it would allow these researchers to
easily derive the MBPD from the MPQ (e.g., Dunedin Multidisciplinary Health Development Study, Caspi,
et al., 1997; Iowa Youth and Families Project, Iowa Single Parent Project; Donnellan, Assad, Robins, &
Conger, 2007; Donnellan, Conger, & Burzette, 2007; Ge & Conger, 1999; Kim, Conger, Lorenz, & Elder,
2001; the Minnesota Study of Twin Reared Apart, Bouchard, Lykken, McGue, Segal, & Tellegen, 1990;
and the Minnesota Twin and Family Study, Iacono, Carlson, Taylor, Elkins, & McGue, 1999).
These and other datasets that include the MPQ can then provide information about BPD that was
previously unavailable. For instance, the calculation of BPD features in these datasets will allow us to
understand the etiological principals, underlying vulnerabilities, longitudinal course, and psychophysiology
of the disorder. In turn, this may lead to a better understanding of prevention, and treatment of this form of
psychopathology.
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Appendix A. Hypotheses
1.

Convergent validity: MBPD scores would show strong, positive correlations with both the
BPD diagnostic measure and self-report measure of BPD.

2.

External correlates:
a. In accordance with previously established correlates of BPD, the MBPD would
demonstrate a significant, moderate, positive correlation with external correlates such as
childhood trauma, Axis I Psychopathology (e.g. Post Traumatic Stress Disorder, PTSD),
distress tolerance, impulsivity, and risky behaviors (e.g. substance use, alcohol use),
and antisocial, or externalizing behaviors.
b. In addition, the MBPD should wield predictive, incremental utility of these external
correlates, such that it uniquely predicts these correlates above and beyond negative
affect, a core component of BPD, and therefore a construct that frequently overlaps with
BPD (Bornovalova et al., 2011a; Bornovalova, Matusiewicz, & Rojas, 2011b; Gratz, Tull,
Baruch, Bornovalova, & Lejuez, 2008;; Trull, Solhan,Tragesser, et al., 2008;; Selby,
Anestis, Bender, 2009; Glenn & Klonsky, 2009) .

3.

Test-retest reliability/Rank Order Stability. The MBPD would exhibit longitudinal stability at
three time points, such that the correlation between administrations at baseline, 7 weeks, and
14 weeks should be strong, positive correlations.

4.

Diagnostic Accuracy:
a. The MBPD will yield good discriminant ability for distinguishing between BPD and non
BPD individuals. This ability will be the similar to the discriminatory ability of the PAI-BOR
for distinguishing between BPD and non-BPD individuals (Bell-Pringle, Pate, & Brown,
1997; Kurtz & Morey, 2001; Morey, 1991, 1996)

5.

Mean Level Change/Individual Level Change:
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a. Given the mixed literature surrounding the stability of BPD traits over time, I did not have
hypotheses regarding the how these traits function over time. Studies suggest that BPD
traits decline over time, especially during young adulthood, e.g. ages 17 - 24
(Bornovalova et al, 2009); similarly, a study of the short-term diagnostic stability of BPD
showed that over 6 months, there was a significant decline in number of criteria met
(Shea et al., 2002). However other studies suggest that BPD is a chronic personality
disorder (e.g. DSM-IV for BPD), and should be consistent over time. Hence, I had no
strict hypotheses regarding the stability or change in BPD traits over time.
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Appendix B. Schedule of Assessments
Table B1.
Schedule of Assessments
Sample

Follow-Up
(A2)
Extern.
& Incr.

Subsample
1

MBPD
PAI-BOR

MINI for Axis
I disorders,
Distress
Tolerance
Measures,
NCHRBS,
UPPS,
Perceived
Stress,
CTQ

Subsample
2

MBPD
PAI-BOR

MINI for Axis
I Disorders,
Self-report
Distress
Tolerance
Measures,
NCHRBS,
UPPS,
Perceived
Stress,
PANAS

MBPD
PAI-BOR
SCID
II:BPD

SCID
II:ASPD
PANAS
CTQ,
MINI for Axis
I Disorders,
Self-report
Distress
Tolerance
Measures,
NCHRBS,
Perceived
Stress,
Externalizing159

Substance Users

Undergraduates

Construct

Follow-Up (A3)

N

Construct
233

MBPD
PAI-BOR

MBPD
PAI-BOR

115

227
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Appendix C. Full Description of Measures
Target measure for validation
Minnesota Borderline Personality Disorder Scale (MBPD; Bornovalova, Hicks, Patrick, Iacono, &
McGue, 2011). The MBPD is a 19-item scale developed using items from the Multidimensional
Personality Questionnaire (MPQ; Tellegen, 1982), a well-validated omnibus measure of normal
personality. Previous work indicates that dimensional measures of BPD such as the Personality
Assessment Inventory-Borderline scale (PAI-BOR; Morey, 1991), the Inventory for Interpersonal
Problems-BPD scale (IIP-BPD; Lejuez et al., 2003; Pilkonis, Yookung, Proietti, & Barkham, 1996), and
DSM-IV based BPD diagnostic interviews strongly correlated with the MBPD (r’s = .80-.89 with PAI-BOR
and estimated PAI-BOR; r’s = .60-.66 with DSM-IV diagnostics; r’s = .60 with IIP-BPD) across normative
and clinical samples (Bornovalova et al., 2011; Bornovalova et al., 2012; Rojas et al., in press).
Additionally, in a sample of young female twins, MBPD scores demonstrated similar heritability as
estimated PAI-BOR scores and a DSM-IV interview based diagnostic screener (Rojas et al., in press).
Finally, consistent with the nomological network that of BPD, MBPD scores exhibited medium to large
correlations with known BPD correlates including negative affect, impulsivity, antisocial behaviors,
interpersonal problems, eating disorders, anxiety disorders, major depressive disorder, and alcohol and
drug use (Bornovalova et al., 2011; Bornovalova et al., 2012; Rojas et al., in press). In both samples,
internal consistency, Cronbach’s α (alpha) was good; substance users (α = .77) and undergraduate
students (Cronbach’s α = .76, α =.74, α = .70 for all three assessments respectively) .
Measures of convergent validity
In both studies (substance users and undergraduate students) the continuous, self-report index of
BPD was the Personality Assessment Inventory Borderline Features Scale (PAI-BOR; Morey, 1991). The
PAI-BOR assesses severe personality pathology that is related to BPD and personality disorders. It
consists of 24 items that are rated on a 4-point scale, and the possible total ranges from (0 –3; false,
slightly true, mainly true, very true).
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This scale taps four empirically derived dimensions for borderline phenomenology: affective instability,
identity problems, negative relationships, and self-harm (Grinker, Werble, & Drye, 1968; Morey, 1988).
Multigroup confirmatory factor analysis showed that the PAI-BOR is measurement invariant across sex
and age (De Moor, et al., 2009). The PAI-BOR has good internal consistency (α = .84; Bornovalova, et
al., 2011; Morey, 1991), high test-retest reliability over a 3-4 week time period (r = .86, Morey, 1991
(Morey, 1991) and good convergent and discriminant validity (Stein, et al., 2007; Trull, 1995). Reliability in
the current samples was as follows. In both samples; substance users and undergraduate students,
Cronbach’s α = .86 and α= .72 respectively.
Only study 1 (substance users) received the diagnostic measure of BPD. Specifically, the
diagnostic measure was the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) to
determine BPD diagnosis as well as symptom count (First, Gibbon, Spitzer, Williams, & Benjamin, 1997).
The interviews were given prior to administration of the self-report measures so there is no prior
knowledge of scores on other self-report measures on the part of the interviewer. Interviews were
conducted by trained graduate students or trained research assistants. In order to measure reliability,
25% of the audio-taped interviews were independently for symptom count and diagnosis by a rater who is
a trained research assistant. If there was discrepancy in symptom ratings and/or diagnosis, consensus
was reached through the aid of a PhD level clinician (M.B). The SCID-II has been shown both high
reliability and validity (Spitzer, Williams, Gibbon, & First, 1989). Inter-rater reliability was  = .74.
Measures of external correlates
Perceived Stress Scale (PSS – Cohen & Williamson, 1988). Both studies (substance users
and undergraduate students) received the PSS, a 10-item scale taken from the original 14-item scale
(Cohen, Kamarck, and Mermelstein, 1983). This scale is aimed at measuring self-report of stress in daily
life over the last month. Items appear on a 4-point scale (0 = Never, 4 = Very often). Items include “In the
last month, how often have you been upset because of something that happened unexpectedly.”
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This measure has demonstrated good validity (Cohen & Williamson, 1988; Cohen & Williamson, 1991)
and short-term reliability (e.g. 4 – 8 weeks; Cohen, Kamarck, and Mermelstein, 1983). In both samples,
substance users and undergraduate students, Cronbach’s α = 72 and α = .85 respectively.
Positive and Negative Affect Scale (PANAS; Watson & Clark, 1988). Both studies (substance
users and undergraduate students) completed the Positive and Negative Affect Schedule (PANAS). The
PANAS assesses affective experiences over the past month, specifically positive feelings α = .84 (i.e.
Enthusiastic) and negative feelings α = .84 (scared). Participants are asked to rate the extent to which
they experienced each particular emotion on a five-point scale (1 = very slightly – 5 = very much) for 20
items. This measure has been accurately discriminates between negative and positive affect (Watson
1998; Chen, Dai, Spector, Jex, 1997; Joiner & Blalock, 1995) such that each scale (negative, positive) is
considered an independent construct and exhibits high test-retest reliability (Crawford & Henry, 2004). In
Study 1 (substance users) for the total scale, positive affect, and negative affect, Cronbach’s α =.85, .90,
.90 respectively. In Study 2 (undergraduate students) for the total scale, positive affect, and negative
affect, Cronbach’s α = .82, .88, .83 respectively.
UPPS-P Impulsive Behavior Scale (UPPS-P; Lynam et al., 2006). Both studies (substance
users and undergraduate students) received the UPPS-P, a 59-item inventory that measures five
subscales of impulsive behavior. The five subscales include Negative Urgency (i.e., “I have trouble
controlling my impulses”), Positive Urgency (i.e., “When I am very happy, I can’t seem to stop myself from
doing things that can have bad consequences.”) (lack of) Premeditation (i.e., ”I have a reserved an
cautious attitude towards life”), (lack of) Perseverance (i.e., “I tend to give up easily”), and SensationSeeking (i.e., “I'll try anything once). The subscales have 11, 13, 12, 10, and 14 items respectively, each
of which are calculated by taking the mean of the items. The items have a 4-point Likert scale (1-strongly
agree to 4-strongly disagree). This measure has demonstrated external validity with antisocial personality
traits, pathological gambling, and borderline personality features (Whiteside, Lynam, Miller, & Reynolds,
2005). In substance users: Negative Urgency: α = .80; (lack of) Premeditation: α = .83; (lack of)
Perseverance: α = .74; Sensation-Seeking: α =.84; Positive Urgency: α = .91, total scale: α = .92.
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In undergraduate students: Negative Urgency: α = .86; (lack of) Premeditation: α = .86; (lack of)
Perseverance: α = .80; Sensation-Seeking: α =.86; Positive Urgency: α = .92, total scale: α = .90.
Externalizing Behaviors. EXT-159 (Venables & Patrick, 2012). Study 2 (substance users)
received the EXT -159, a self-report measure of externalizing behaviors and traits. This measure is
adapted from the 415-item version and 100-item version of the Externalizing Spectrum Inventory (ESI,
Bernat, et al., 2011; Nelson, et al., 2011; Hall, Bernat & Patrick, 2007; Blonigen et al., 2011) and has
been shown to represent all 23 subscales of the ESI. Items appear on a 4-point scale (1 = True, 4 =
False). The scale has four subscales: disinhibition (DIS), callous-aggression (AGG), and substance
abuse (SUB). Item examples for each of the three subscales include, “I get in trouble for not considering
the consequences of my action (DIS);” “I’ve told lies about someone just to see how it would affect them
(AGG),” “I’ve smoked marijuana at a party (SUB).” The EXT-159 has demonstrated good validity in
previous study (Venable & Patrick, 2012). In substance users, total score was used, Cronbach’s α = .99.
Distress Tolerance. In both studies substance users and undergraduate students, received selfreport measures of distress tolerance at A1. For purposes of data reduction, I performed a principal
components analysis and calculated a regression score for three self-report measure (loadings were
>|.5|) in order to create a distress tolerance factor.
Frustration Discomfort Scale (FDS; Harrington, 2005b). Both studies (substance users and
undergraduate students) received self-report questionnaires of an individual’s tolerance to distress. It
consists of 35 items, with four 7-item subscales: discomfort intolerance, entitlement, emotional
intolerance, and achievement. Apart from two items, all statements were worded only in terms of
frustration intolerance. Individuals were asked to rate the strength of belief on a 5-point Likert-type scale
(1 – absent; 5 – very strong). This measure has demonstrated both good internal consistency (α ≥ .84;
Harrington, 2005b; Harrington, 2005a) and discriminant validity. Internal consistency of this measure is
high in previous studies (α ≥ .84; Harrington, 2005b). In both samples, substance users and
undergraduate students, Cronbach’s α = .94 and .92 respectively.
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Distress Tolerance Scale- DTS (Simons & Gaher, 2005). Both studies (substance users and
undergraduate students) received the self-report questionnaire of an individual’s tolerance to stress. It
consists of 16 items reflecting four subscales: ability to tolerate emotional distress, appraisal of distress,
absorbed by negative emotion, and regulation efforts to alleviate distress. Items are rated on a 5-point
scale (1 – Strongly agree; 5 – Strongly disagree). Example items include, “I can’t handle feeling
distressed or upset”. This measure has demonstrated both good reliability and validity (reliability: r = .61;
internal consistency: α = .80; Simons & Gaher, 2005). Previous studies have shown that these measure
correlate with BPD, such that BPD individuals evidence lower tolerance to stress in comparison to normal
population (Chapman, Gratz, & Brown, 2006; Gratz, Rosenthal, Tull, Lejuez, & Gunderson, 2006). This
self-report measure has been shown to be reliable and valid measures of an individual’s tolerance to
stress (Simons & Gaher, 2005). In both samples, substance users and undergraduate students,
Cronbach’s α = .89 and .86 respectively.
Tolerance of Negative Affective States Scale – (TNASS - Bernstein and Brantz, 2012). Both
studies (substance users and undergraduate students) received this 25-item self-report questionnaire
examining an individual’s tolerance of negative emotions. Participants were asked to rate mood items,
(e.g. “sad” or “angry”) and how tolerant they are of these emotions (1 = intolerant, 5 = very tolerant).
Tolerance and intolerance are defined in the measure’s completion directions. This measure has shown
good internal consistency α = .92 and has been related to other measures of distress tolerance while
discriminating from other measures of pure negative affect (Bernstein & Brantz, 2012). In both samples,
substance users and undergraduate students, Cronbach’s α = .96 and .93 respectively.
Childhood abuse. Both studies (substance users and undergraduate student) received this self-report
measure that assesses experiences with childhood abuse, the Childhood Trauma Questionnaire-Short
Form (CTQ-SF; Bernstein et al., 2003). The CTQ-SF is a 28-item measure that assesses childhood
maltreatment experiences (i.e., "while you were growing up") using a five-point scale ranging from 1
(never true) to 5 (very often true) across physical, sexual, and emotional abuse, and physical and
emotional neglect.
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Sample items include: “Someone tried to touch me in a sexual way, or tried to make me touch them,”
“People in my family hit me so hard that it left me with bruises or marks,” and “People in my family called
me things like ‘stupid,’ ‘lazy,’ or ‘ugly.’” The CTQ-SF has good sensitivity (.78 –.86) and satisfactory
specificity (.61–.76) when self-reports are compared with trauma ratings from child welfare records and
reports of family members and clinicians (Bernstein, et al., 2003). Similarly, among a sample of adult
substance abusers, the CTQ demonstrated good test-retest reliability over a period of greater than 1
month (r = .86, p < .01; see Bernstein & Fink, 1998). In the current studies I utilized the subscale of abuse
(sexual, physical, and emotional abuse. In both samples, substance users and undergraduate students,
Cronbach’s α = .89 and .91, respectively for the subscale of abuse.
Antisocial Personality Disorder. Study 1 (substance users) received diagnostic interviews for
conduct disorder and adult antisocial behavior based on the Structured Clinical Interview for DSM-IV Axis
II Disorders (SCID-II ASPD) to determine both symptom count and diagnosis for both (First, et al., 1997).
In order to measure reliability, 25% of the audio taped interviews will be rated independently for symptom
count and diagnosis by two raters who will be trained research assistants. If there were discrepancies in
symptom ratings and/or diagnosis, consensus will be reached with the aid of a PhD level psychologist
(M.B). This measure has been shown both high reliability and validity (Spitzer, Williams, Gibbon, & First,
1990). In Sample 1 (substance users) inter-rater reliability was CD ( = .96) and for AAB ( = .67).
Axis I Psychopathology. Both studies (substance users and undergraduate students) received
the Mini-International Neuropsychiatric Interview (M.I.N.I.; Sheehan et al., 1999), a short structured
diagnostic interview for DSM-IV and ICD-10 disorders, including Major Depressive Disorder (MDD),
Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), and Alcohol and
Substance Abuse/Dependence and Panic Disorder (PD). Symptom counts were assessed. In order to
measure reliability, 25% of the audio-taped interviews were rated independently for symptom count and
diagnosis by two raters who are trained research assistants. If there were discrepancies in symptom
ratings and/or diagnosis, consensus was through the aid of a PhD level clinician (M.B.). Kappas were as
follows for each individual diagnosis.
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For undergraduate students: MDD (current  = .84, lifetime  = .79), PTSD ( = 1.00), PD ( = 1.00),
GAD(  = .74), alcohol dependence (1.00), substance dependencies ( = 1.00). For substance users:
MDD (current  = .94; lifetime  = 1.00), PD ( = .95), PTSD ( = 1.00), GAD ( = .93), AD ( =1.00),
substances dependencies (s range from .96 – 1.00). This interview has shown concordance with the
Structure Clinical Interview for Axis I DSM-IV Disorders (SCID-I; Sheehan, Lecrubier, & Sheehan, 1998).
First, descriptives were conducted for symptoms counts of each individual diagnoses, and those which
exhibited unacceptable skew (>|2|) and kurtosis (>|7|), were log transformed in order to reflect a more
normal distribution. In substance users, and undergraduate students, the following variables were log
transformed because they exhibited skew and kurtosis outside the acceptable range: MDD current
symptoms: 2.24 and 3.79 respectively; PD past symptoms 3.58 and 12.60 respectively; PTSD 2.97 and
8.78 respectively, current DD: 5.85 and 36.71. In both studies the following variables were calculated
according to the same procedure. A max count was taken across current and past MDD symptoms to
create a variable that indexed symptoms of MDD ever experienced. A composite variable for anxiety was
calculated by taking the mean z-score of symptoms for these three disorders (current GAD, current
PTSD, and lifetime PD). A composite variable for current substance dependence was calculated by taking
a max count of dependence symptoms across drug classifications. A max count for current alcohol
dependence symptoms was calculated.
National College Health Risk Behavior Survey (NCHRBS; Center for Disease Control, 1995). Both
studies (substance users and undergraduate students) received the NCHRBS, a 77-item questionnaire
that assesses six areas of behavior that affect the morbidity and mortality of adolescents and young
adults. The CDC (Center for Disease Control) revised the instrument in 1995 for a total of 96 questions.
NCHRBS is the first national survey to measure health risk behaviors among undergraduate students in
all six areas. The six areas of health behavior remained unchanged behaviors that contribute to
unintentional and intentional injuries; tobacco use; alcohol and other drug use; sexual behaviors that
contribute to unintended pregnancy and STDs; unhealthy dietary behaviors; and physical inactivity. A
max count was performed for two areas of alcohol use and drug use in the past year.
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